Keith Adrian Powell
Presidente presso Pharmidex Pharmaceutical Services Ltd.
Profilo
Keith Adrian Powell is currently the Chairman at Pharmidex Pharmaceutical Services Ltd.
He is also the Director at Oppilotech Ltd.
since 2015 and the Executive Partner at Longbow Capital LLP since 2012.
Previously, Dr. Powell served as the Chief Executive Officer at PolyTherics Ltd.
from 2005 to 2011.
He was also the Executive Chairman at Domainex Ltd.
from 2007 to 2009.
Additionally, he held positions as Chairman at Canbex Therapeutics Ltd., BioMoti Ltd., and Genex Biosystems Ltd.
He worked as a Principal at AstraZeneca PLC and as a Senior Vice President at Maxygen, Inc. Dr. Powell was also the Head of Intellectual Property & Discovery at Zeneca Garden Care.
Dr. Powell obtained his undergraduate degree from Colorado Mesa University.
Posizioni attive di Keith Adrian Powell
Società | Posizione | Inizio |
---|---|---|
Longbow Capital LLP
Longbow Capital LLP Investment ManagersFinance Longbow Capital LLP (Longbow Capital) is a private equity firm founded in 2004 by Jonathan Powell, Edward Beckett, Robin Finlayson, Kevin Doyle, Colin Bothway, Ron Petersen and Edward Rudd. The firm is headquartered in Norwich, United Kingdom. | Investitore di Private Equity | 19/05/2010 |
Pharmidex Pharmaceutical Services Ltd.
Pharmidex Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom. | Presidente | - |
Oppilotech Ltd.
Oppilotech Ltd. Miscellaneous Commercial ServicesCommercial Services Oppilotech Ltd. engages in developing safe antibacterial compounds against drug resistant organisms. The company was founded by John George and Ajay Mistry on January 7, 2014 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 08/01/2015 |
Precedenti posizioni note di Keith Adrian Powell
Società | Posizione | Fine |
---|---|---|
Canbex Therapeutics Ltd.
Canbex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Canbex Therapeutics Ltd. engages in the development of novel peripherally-acting cannabinoid agonists and mimetics for the treatment of multiple sclerosis spasticity and pain. Its lead drug candidate, VSN 16, has been established as a potent, stable and orally-available agonist of GPR-55 with a clear anti-spasticity effect in a validated preclinical model. The company was founded by David Baker, Gavin Giovannoni, Cristina Visintin, Gareth Pryce and David Lawrence Selwood in 2005 and is headquartered in London, the United Kingdom. | Presidente | 08/07/2019 |
Genex Biosystems Ltd.
Genex Biosystems Ltd. BiotechnologyHealth Technology Genex has developed the world's most efficient vector system (LipTide) for delivery of DNA, RNA and drugs into cells for gene expression, gene knockdown and drug therapy. LipTide technology is available for licensing to companies developing DNA or RNA based therapies. The company was founded in 2002 and is headquartered in London, GB. | Direttore/Membro del Consiglio | 16/02/2012 |
PolyTherics Ltd.
PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom. | Amministratore Delegato | 25/05/2011 |
BioMoti Ltd.
BioMoti Ltd. Hospital/Nursing ManagementHealth Services BioMoti Ltd. provides cancer treatment and health care services. It offers a new class of immunotherapeutic drug-loaded particles that target and gain entry to the tumor vasculature and cancer cells. The company was founded by Joanne Martin and Davidson Ateh on June 6, 2009 and is headquartered in London, the United Kingdom. | Presidente | - |
Zeneca Garden Care
Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million. | Corporate Officer/Principal | - |
Formazione di Keith Adrian Powell
Colorado Mesa University. | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ASTRAZENECA PLC | Health Technology |
Aziende private | 10 |
---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
Zeneca Garden Care
Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million. | Health Technology |
Longbow Capital LLP
Longbow Capital LLP Investment ManagersFinance Longbow Capital LLP (Longbow Capital) is a private equity firm founded in 2004 by Jonathan Powell, Edward Beckett, Robin Finlayson, Kevin Doyle, Colin Bothway, Ron Petersen and Edward Rudd. The firm is headquartered in Norwich, United Kingdom. | Finance |
Domainex Ltd.
Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Health Technology |
Canbex Therapeutics Ltd.
Canbex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Canbex Therapeutics Ltd. engages in the development of novel peripherally-acting cannabinoid agonists and mimetics for the treatment of multiple sclerosis spasticity and pain. Its lead drug candidate, VSN 16, has been established as a potent, stable and orally-available agonist of GPR-55 with a clear anti-spasticity effect in a validated preclinical model. The company was founded by David Baker, Gavin Giovannoni, Cristina Visintin, Gareth Pryce and David Lawrence Selwood in 2005 and is headquartered in London, the United Kingdom. | Health Technology |
PolyTherics Ltd.
PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom. | Health Technology |
Genex Biosystems Ltd.
Genex Biosystems Ltd. BiotechnologyHealth Technology Genex has developed the world's most efficient vector system (LipTide) for delivery of DNA, RNA and drugs into cells for gene expression, gene knockdown and drug therapy. LipTide technology is available for licensing to companies developing DNA or RNA based therapies. The company was founded in 2002 and is headquartered in London, GB. | Health Technology |
Pharmidex Pharmaceutical Services Ltd.
Pharmidex Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom. | Health Technology |
BioMoti Ltd.
BioMoti Ltd. Hospital/Nursing ManagementHealth Services BioMoti Ltd. provides cancer treatment and health care services. It offers a new class of immunotherapeutic drug-loaded particles that target and gain entry to the tumor vasculature and cancer cells. The company was founded by Joanne Martin and Davidson Ateh on June 6, 2009 and is headquartered in London, the United Kingdom. | Health Services |
Oppilotech Ltd.
Oppilotech Ltd. Miscellaneous Commercial ServicesCommercial Services Oppilotech Ltd. engages in developing safe antibacterial compounds against drug resistant organisms. The company was founded by John George and Ajay Mistry on January 7, 2014 and is headquartered in London, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Keith Adrian Powell